India's first indigenous CAR-T therapy and gene therapy for Hemophilia, discussed during the 7th PM-STIAC meeting in January 2025, were presented by experts from which institutions?

NIPER and PGIMER, Chandigarh

CSIR and JIPMER, Puducherry

IIT Bombay and St. John's Hospital, Bengaluru

IISc, Bengaluru, and AIIMS, Delhi

APEDIA

NTPC Graduate Tier 1

2025 • 05 Jun, 2025 • Shift-3

India's first indigenous CAR-T therapy and gene therapy for Hemophilia, discussed during the 7th PM-STIAC meeting in January 2025, were presented by experts from which institutions?

Correct Answer

IIT Bombay and St. John's Hospital, Bengaluru

[Scientific Milestone Context]: Hemophilia gene therapy and cutting-edge CAR-T cell therapy represent massive leaps in homegrown medical biotechnology, aiming t......

💡 Analysis & Explanation

[Scientific Milestone Context] ▼

Hemophilia gene therapy and cutting-edge CAR-T cell therapy represent massive leaps in homegrown medical biotechnology, aiming to drastically reduce the cost of terminal illness treatments in India.

[Institutional Collaboration] ▼

Developing these sophisticated immunological frameworks requires deep cross-disciplinary synergy between top-tier engineering institutes and advanced clinical research hospitals.

[Meeting Specifics] ▼

Official proceedings of the 7th Prime Minister's Science, Technology, and Innovation Advisory Council (PM-STIAC) explicitly highlighted the pioneering presentations delivered jointly by researchers from a premier tech institute in Mumbai and a leading medical college in Bangalore.

Conclusion ▼

IIT Bombay and St. John's Hospital, Bengaluru were the presenting institutions.

Choose Language

See you soon!

India's first indigenous CAR-T therapy and gene therapy for Hemophilia, discussed during the 7th PM-STIAC meeting in January 2025, were presented by experts from which institutions?